new York According to study data, the Moderna vaccine still appears to be effective against the new Omikron variant after three doses. The booster with a dosage of 50 micrograms increases the omicron-neutralizing antibody level by around 37 times, Moderna said with reference to preliminary data. A booster dose over 100 micrograms increases the antibody level around 83 times compared to the level before the booster vaccination.
“In order to respond to this highly transferable variant, Moderna will continue to advance the development of an Omikron-specific booster candidate and quickly bring it into the clinical test phase, should this become necessary in the future,” says CEO Stéphane Bancel. Moderna shares rose in pre-market trading by around 6.5 percent.
The manufacturers Biontech / Pfizer recently announced that initial data indicated that their vaccine against the Omikron variant was effective.
More: Novavax vaccine before approval: these are the most important questions and answers
Top jobs of the day
Find the best jobs now and
be notified by email.